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Risk Factors for Neurologic Complications of Hand, Foot and 
Mouth Disease in the Republic of Korea, 2009
In 2009, the first outbreak of hand, foot and mouth disease (HFMD) or herpangina (HP) 
caused by enterovirus 71 occurred in the Republic of Korea. This study inquired into risk 
factors associated with complications of HFMD or HP. A retrospective medical records 
review was conducted on HFMD or HP patients for whom etiologic viruses had been 
verified in 2009. One hundred sixty-eight patients were examined for this investigation. 
Eighty patients were without complications while 88 were accompanied by complications, 
and 2 had expired. Enterovirus 71 subgenotype C4a was the most prevalent in number 
with 67 cases (54.9%). In the univariate analysis, the disease patterns of HFMD rather than 
HP, fever longer than 4 days, peak body temperature over 39°C, vomiting, headache, 
neurologic signs, serum glucose over 100 mg/dL, and having an enterovirus 71 as a 
causative virus were significant risk factors of the complications. After multiple logistic 
analysis, headache (Odds ratio [OR], 10.75; P < 0.001) and neurologic signs (OR, 42.76; 
P < 0.001) were found to be the most significant factors. Early detection and proper 
management of patients with aforementioned risk factors would be necessary in order to 
attain a better clinical outcome.
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INTRODUCTION
Hand, foot and mouth disease (HFMD) is a common acute viral 
illness with fever, oral ulcers, and vesicular rashes on the hands, 
feet and buttock as characteristics features. HFMD occurs most 
frequently by coxsackievirus A16, and is caused by various en-
teroviruses including enterovirus 71. Herpangina (HP) has char-
acteristics of having fever and oral ulcers without skin rash, and 
is developed by various enteroviruses likewise HFMD. HFMD 
or HP is generally known as a self-limiting disease that shows a 
mild clinical course. However, enterovirus 71-induced HFMD 
or HP may often show a severe clinical course, accompanied by 
neurologic complications, and may lead to death (1). 
 Ever since enterovirus 71 was first recognized in California in 
1969, it has been epidemic everywhere in the world (2, 3). Par-
ticularly, in the late 1990s, enterovirus 71-caused HFMD and 
HP largely developed and continuously led to death due to their 
complications in the Asian countries of the Western Pacific such 
as Malaysia (4), Taiwan (5), Japan (6), Singapore (7), and China 
(8). The Republic of Korea (ROK) is located geographically ad-
jacent to these countries. Ever since enterovirus 71-caused spo-
radic cases of the year 2000 developed in the ROK (9), enterovi-
rus 71-induced epidemic or death did not occur until 2009 when 
another epidemic and associated death by enterovirus 71-caused 
HFMD surfaced (10). Thus, some cases, especially enterovirus 
71-caused HFMD or HP patients, may show a clinical course of 
rapid exacerbation accompanied by complications. According-
ly, understanding of risk factors accompanied by complications 
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and their management are imperative.
 Two study results were already reported on the ROK’s epidem-
ic in 2009 (10, 11). Nevertheless, these studies utilized merely 
the data entered into the Nationwide Enterovirus Sentinel Sur-
veillance System and did not include detailed medical records 
review on each case. Thus, this study sought risk factors associ-
ated with complications after examined the clinical features and 
laboratory findings though the medical records of patients ad-
mitted to the hospital with HFMD or HP confirmed for etiologic 
viruses, which were endemic in the ROK in 2009.   
MATERIALS AND METHODS
Study setting 
The Enterovirus Sentinel Surveillance System in the ROK con-
sists of 8 primary hospitals, 12 secondary hospitals and 40 ter-
tiary hospitals. Specimens from patients suspected of enterovi-
ruses infection are sent to the Division of Hepatitis and Enteric 
Viruses, Korea Center for Disease Control and Prevention (KCDC). 
Patients’ clinical data are entered into the web-based system. 
Using specimens from stool, throat swab and cerebrospinal flu-
id (CSF), cell culture, PCR and genetic sequencing are carried 
out with respect to enteroviruses at the KCDC.  
 Two thousand four-hundred twenty-seven cases suspected 
of enteroviruses infection were registered into the Enterovirus 
Sentinel Surveillance System from January through December, 
2009. Among them, 519 cases were HFMD or HP and enterovi-
ruses were detected in 321 patients from 24 hospitals. This study 
excluded 132 outpatients and requested medical record review 
on 189 patients who were admitted and treated at each hospi-
tal. Among them, a total of 168 patients were able to undergo a 
medical record review (Fig. 1). Clinical data were collected by 
each hospital in structured manner for the period from April 
through August, 2010.
 
Virus detection
One to 3 specimens among throat swab, endotracheal aspirates, 
rectal swab, stool or CSF were collected depending on each pa-
tient. Enteroviruses genome detection was attempted by real-
time reverse transcription–PCR (RT-PCR) by using TaqMan tech-
nology (Applied Biosystems, Foster City, CA, USA). A causative 
organism was determined in cases of detecting one or more vi-
ruses among them. 
 Briefly, viral RNAs were extracted by using the magnetic bead–
based viral nucleic acid purification protocol described by Boom 
et al. (12). Subsequently, 1-step real-time RT-PCR was performed 
by using a dual-labeled fluorogenic enteroviruses-specific probe 
and primers designed on the basis of previous data (13). For ge-
notyping, seminested RT-PCR was used to amplify part of the 
viral protein 1 (VP1) gene of enteroviruses, based on the KCDC 
protocol for detection of pan-enteroviruses, and sequencing 
analysis for VP1 amplicon was performed by using the auto-
matic sequencer and the DNAstar software package (14).
Case definitions
HFMD was defined as having vesiculo-papular rashes over the 
hands, soles, or buttocks with mouth ulcers while HP was de-
fined as having oral ulcers without any skin rash. Cases with 
development of complications were categorized as the cases 
accompanied by aseptic meningitis, encephalitis, encephalo-
myelitis, and polio-like syndrome (PLS). Aseptic meningitis was 
defined as having clinical signs or symptoms of meningitis with 
pleocytosis (leukocyte > 5 cells/μL) with negative bacterial cul-
ture in the CSF obtained from a lumbar puncture. Encephalitis 
was defined as having CSF pleocytosis with a change in con-
sciousness. PLS was defined as having acute weakness in the 
extremities with a drop in muscle power or deep tendon reflex. 
Encephalomyelitis was defined as having encephalitis and PLS 
simultaneously. 
Data collection 
Data were collected for demographic information, past medical 
history, contact history of enteroviruses associated diseases, vital 
signs (the presence of fever, peak body temperature, etc.), symp-
toms and signs at presentation during the whole course of dis-
ease. Collected also were laboratory data including white blood 
cell and platelet count, hemoglobin, C-reactive protein (CRP), 
erythrocyte sedimentation rate, blood glucose and cell counts, 
glucose and protein in CSF, and isolated virus and subtype. 
Clinically diagnosed with other 
diseases like aseptic meningitis or 
fever without a focus (N = 1,908)
HFMD or HP cases that virus was  
not detected (N = 198)
Medical recored were not available 
(N = 21)
Medical recored were available and 
included in this study (N = 168)
Virus confirmed HFMD or HP cases 
who were cared at outpatient clinic 
(N = 132)
Total suspected EV infection cases  
that were reported to KCDC  
(N = 2,427)
Clinically diagnosed with HFMD or  
HP cases (N = 519)
Virus confirmed HFMD or HP cases  
(N = 321)
Virus confirmed HFMD or HP cases  
who were admitted (N = 189)
Fig. 1. The flow chart shows how we selected the study population in this study. EV, 
enterovirus; HFMD, hand, foot and mouth disease; HP, herpangina; KCDC, Korea 
Centers for Disease Control and Prevention.
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Statistical analysis 
We analyzed the data using SPSS 13.0 software (SPSS Inc., Chi-
cago, IL, USA). We analyzed fever duration, peak fever, clinical 
symptom (vomiting, diarrhea, poor oral intake, headache), neu-
rologic sign (jerking, gaze palsy, tremor, dysarthria, ataxia, gait 
disturbance, upper or lower extremity weakness, insomnia, sei-
zure, lethargy, coma), laboratory test (white blood cell count, 
erythrocyte sedimentation rate, CRP, glucose) and isolated virus 
type as a risk factor. Normally distributed data were compared 
using Student’s t test; data that were not normally distributed 
were compared by the Mann-Whitney U test. Categorical data 
were tested using the chi-square test or Fisher’s exact test. A mul-
tiple logistic regression analysis was used to examine the multi-
variate-adjusted odds ratios for risk factors that were significant 
in univariate analysis. A P  value less than 0.05 was considered 
statistically significant.
Ethics statement
The study protocol was approved by the institutional review 
board of The Catholic Medical Center of The Catholic Universi-
ty of Korea (Approval No. XC10RNMI0022). Informed consent 
was waived by the board.
RESULTS
Among 189 patients from 24 hospitals subject to investigation, 
168 patients (88.9%) from 21 hospitals (87.5%) underwent a med-
ical record review. Among these subjects, 80 patients (47.6%) 
were not accompanied by complications while 88 patients (52.4 
%) had complications. Of those 88 patients that developed com-
plications, 56 patients (33.3%) had aseptic meningitis, 18 pa-
tients (10.7%) had encephalitis or encephalomyelitis, and 14 
patients (8.3%) had PLS. Of those 18 subjects with encephalitis 
or encephalomyelitis, 4 patients (25%) were accompanied by 
cardiopulmonary complications and 2 of these 4 patients ex-
pired (Table 1).
Demographic data
Of those 168 patients who were investigated, 103 patients (68.3%) 
were males and 65 patients (38.7%) were females with the ratio 
of 1.58:1. The overall median age was 28.0 months (with a range 
16.5-49.5). With respect to the age at which the disease occurs, 
the peak incidence was shown just before and after 12 months. 
Ninety two point nine percent of these patients were less than 
5 yr old (152/168) (Fig. 2). There was no statistically significant 
difference in the male-female ratio between the group with com-
plications and the group without complications, but the group 
with complications was significantly older (P = 0.041) and heavier 
(P = 0.002), and had a longer hospital stay (P < 0.001) (Table 2). 
Outbreak pattern
The patients showed distinctive seasonal prevalence. A death 
occurred in early May and the number of patients rapidly in-
creased thereafter showing the peak incidence in near summer 
between May and July (Fig. 3).
Table 2. Demographic characteristics of each complicated versus non-complicated group of hand, foot and mouth disease or herpangina in the Republic of Korea, by age 
group on 2009
Characteristics Total cases Non-complicated cases (n = 88) Complicated cases (n = 80) P
Male:Female 1.58:1 1.35:1 1.84:1 0.334
Age (month)*   28.0 (16.0-48.8)   24.0 (14.3-39.8)   33.5 (18.0-56.5) 0.041
Body weight (kg)*   13.0 (11.0-17.0) 12.1 (9.8-15.7)   14.5 (12.0-19.1) 0.002
Length of hospitalization (day)* 5.0 (4.0-7.0) 4.0 (3.0-5.0) 6.0 (5.0-8.0) 0.000
*Data are presented as median (25-75 %tile range). 
Table 1. Classification of various clinical syndrome of virus confirmed hand, foot and 
mouth disease or herpangina
Clinical syndrome No. of patients (%)
Hand, foot and mouth disease or herpangina without 
   complication
  80 (47.6)
Hand, foot and mouth disease or herpangina with 
   complications
  88 (52.4)
   Aseptic meningitis only
   Encephalitis or encephalomyelitis
      without cardiopulmonary complication
      with cardiopulmonary complications
      with cardiopulmonary complications with death
    Polio-like myelitis
56 (33.3)
18 (10.7)
14 (8.3)
2 (1.2)
2 (1.2)
14 (8.3)
Total 168 (100)
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Fig. 2. Number of hand, foot and mouth disease or herpangina in the Republic of Ko-
rea in 2009, by age group. mo, months; yr, years.
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Clinical manifestations
Patients were admitted to the hospital with fever that lasted for 
the median period of 2 days prior to admission. Fever continued 
for the median period of 4 days. Of those 168 subjects examined, 
133 patients (79.2%) had HFMD while 35 patients (20.8%) had 
HP. The group with complications had more incidences of HFMD 
than HP (P = 0.002), had a longer period of fever (P = 0.001) and 
a higher fever over 39°C (P = 0.028). This group more frequently 
showed headache (P < 0.001), vomiting (P < 0.001) and one or 
more neurologic signs/symptoms (P < 0.001). In the group with 
complications, ataxia, gait disturbance, lower extremity weak-
ness, seizure, lethargy and coma, among above neurologic signs 
and symptoms, were shown statistically more often (Table 3).
Laboratory findings 
There was no statistical difference in ratio of patients with leu-
kocytosis between the group with complications and without 
complication (P = 0.465). The mean CRP of the group with com-
plications (1.09 ± 2.05 mg/dL) was lower than that of the group 
without complications (1.47 ± 1.81 mg/dL) (P = 0.022). The mean 
serum glucose of the group with complications was 110.3 ± 30.8 
mg/dL while that of the group without complications was 98.3 ±  
26.4 mg/dL, showing a higher level for the former (P = 0.003) 
(Table 4). 
Viral characteristics
Throat swabs from 92 patients were obtained for virus isolation 
and 51 (55.4%) were positive for enteroviruses. Of those 154 pa-
tients who had a rectal swab or stool sample for virus isolation, 
146 (94.8%) were positive. However, 40 patients had a CSF sam-
ple for virus isolation and only 3 patients (7.5%) were positive 
(Fig. 4).
 Enterovirus 71 was isolated in 122 patients (72.6%), showing 
the largest number of cases. Other isolated viruses detected were 
Table 4. Laboratory findings of each complicated versus non-complicated group of hand, foot and mouth disease or herpangina in the Republic of Korea in 2009, by age group
Laboratory items Total cases
Non-complicated cases  
(n = 88)
Complicated cases  
(n = 80)
P
White blood cell count (cells/µL)* 12,255 ± 4,636 12,847 ± 4,970 11,724 ± 4,256 0.118
Leukocytosis†   22 12 10 0.645
Erythrocyte sedimentation rate (mm/hr)*   23.5 ± 17.6 26.0 ± 20.1   18.4 ± 12.5 0.230
C-reactive protein (mg/dL)*   1.27 ± 1.95 1.47 ± 1.81   1.09 ± 2.05 0.022
Glucose (mg/dL)* 104.5 ± 29.3 98.3 ± 26.4 110.3 ± 30.8 0.003
Glucose > 100 mg/dL†   85 33 52 0.011
Glucose > 150 mg/dL†     9   4   5 0.822
Enterovirus 71† 122 46 76 0.000
Non-Enterovirus V71†   46 34 12 0.000
*These data are shown as mean± SD; †These date are shown as number of patients.
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Fig. 3. Distribution of hand, foot and mouth disease or herpangina in the Republic of 
Korea in 2009, by date. The arrows indicate the dates of onset of the two fatal cases.
Table 3. Clinical manifestations of each complicated versus non-complicated group 
of hand, foot and mouth disease or herpangina in the Republic of Korea in 2009, by 
age group
Characteristics
Total  
cases
Non- 
complicated 
cases 
(n = 88)
Complicated 
cases 
(n = 80)
P
Fever before admission (days)* 2.0  
(1.0-3.0)
2  
(1.0-3.0)
2.0  
(1.0-3.0)
0.206
Total fever duration (days)* 4.0  
(2.0-5.0)
3.0  
(2.0-5.0)
4.0  
(3.0-5.5)
0.001
Peak fever over 39°C† 30 30 39 0.028
Fever duration over 4 days† 85 30 55 0.001
Vomiting† 74 24 50 0.000
Diarrhea† 12 4 8 0.304
Poor oral intake† 113 59 54 0.088
Headache† 46 7 39 0.000
Neurologic sign† 57 7 50 0.000
Jerking† 11 3 8 0.162
Gaze palsy† 6 1 5 0.122
Tremor† 3 0 3 0.096
Dysarthria† 5 1 4 0.209
Ataxia† 5 0 5 0.030
Gait disturbance† 17 0 17 0.000
Upper extremity weakness† 1 0 1 0.524
Lower extremity weakness† 14 1 13 0.002
Insomnia† 2 0 2 0.175
Seizure† 11 1 10 0.008
Lethargy† 28 5 23 0.001
Coma† 5 0 5 0.030
*These data are shown as median (25-75 %tile range); †These date are shown as 
number of patients.
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coxsackievirus A2, A5, A6, A12, A16, coxsackievirus B1, echovi-
rus 9 and untypable enterovirus. Among cases with enterovirus 
71 isolation, 67 cases (54.9%) belonged to the subgenogroup 
C4a. This was shown to be 97% of homologous to enterovirus 
71 subgenogroup that was endemic in China, 2008.
Risk factor analysis 
The group with complications and the group without complica-
tions were compared by univariate analysis. It was found that 
significant risk factors for complications included a rash form 
of HFMD, fever longer than 4 days, peak body temperature over 
39°C, vomiting, headache, neurologic sign (such as jerking, gaze 
palsy, tremor, dysarthria, ataxia, gait disturbance, extremity weak-
ness, insomnia, seizure, lethargy, coma), glucose over than 100 
mg/dL and enterovirus 71 as a causative virus. After multiple 
logistic analysis, headache (Odds ratio [OR], 10.75; P < 0.001) 
and neurologic sign (OR, 42.76; P < 0.001) were the most signif-
icant factors (Table 5).
DISCUSSION
In the late 1990s, the large outbreaks of HFMD or HP caused by 
enterovirus 71 continuously occurred in the neighbor countries 
of the ROK and many deaths had occurred (4-8). Thus, a large 
outbreak of HFMD or HP was also a matter of concern in the 
ROK. According to the Enterovirus Sentinel Surveillance Sys-
tem of the ROK, there was no HFMD or HP caused by enterovi-
rus 71 up until 2008, but the outbreaks of HFMD or HP caused 
by enterovirus 71 and deaths occurred from the year 2009. Ac-
cordingly, this study attempted to understand more accurately 
the epidemic aspect of large outbreaks of HFMD or HP that oc-
curred in the ROK in 2009, and to analyze the risk factors asso-
ciated with complications.
 In this study, the ratio of males and females of HFMD or HP 
incidences was 1.58:1 while 93.8% of all patients were under the 
age of five years. The largest number of patients was especially 
around the age of one year. Deaths occurred at around the age 
of one year, despite the fact that only two had expired. This re-
sult concurred with that of other studies (15-18). 
 As the patients are younger, there are higher possibility of com-
plications and death from HFMD or HP. Nevertheless, neuro-
logic signs are often subtle and easily overlooked (19, 20). Thus, 
in times of HFMD or HP epidemic, careful observations with 
respect to occurrences of complications of patients are neces-
sary in their early childhood. The HFMD or HP epidemic in the 
ROK was manifested largely in the period from May through 
August, 2009. It almost did not occur after October that year, 
which was similar to what was seen in other neighbor countries 
(15, 20). However, owing to the possibility of a continuous epi-
demic regardless of any particular season, it is necessary to put 
together a well-built sentinel surveillance system and to estab-
lish an early warning system for the national public in times of 
an epidemic.     
 Complications of HFMD or HP disclosed the spectrum of dis-
ease severity. Complications began largely in the form of asep-
tic meningitis. Then, they progressed to the state of meningo-
encephalitis that manifested a change of consciousness. How-
ever, some patients did not show any change of consciousness, 
instead of complications progressed to PLS. Well-known already 
was the report that enterovirus 71 caused complications in the 
form of not only meningoencephalitis but also PLS (21). Entero-
virus 71 virus is on the rise as the most important causative virus 
for the PLS in the Western Pacific region where polio viruses 
had been eradicated (22).  
 It was reported that enterovirus 71 that often brought about 
complications would have a tissue tropism in the brain stem, 
cerebellum and spinal cord anterior horn cell (23). Clinical man-
ifestations may change depending on the body tissues where 
these viruses first act upon. The possibility of complications pro-
gression is high in cases of change of consciousness such as irri-
tability or lethargy, as well as manifestations of neurologic symp-
toms, such as ataxia, tremor, lower extremity weakness, inability 
to walk and decreased deep tendon reflex. Thus, careful obser-
Table 5. Multivariated risk factor analysis of complications of hand, foot and mouth 
disease or herpangina
Risk factors
Odds ratio  
(95% Confidence Interval)
P
Peak fever ≥ 39°C 1.03 (0.39-2.74) 0.958
Fever duration ≥ 4 days 1.27 (0.48-3.36) 0.636
Rash of hand, foot and mouth disease 2.87 (0.72-11.48) 0.135
Vomiting 1.20 (0.47-3.07) 0.699
Headache 10.75 (3.56-32.52) 0.000
Neurologic sign 15.00 (4.95-45.4) 0.000
Serum glucose > 100 mg/dL 1.35 (0.56-3.24) 0.508
Enterovirus 71 1.20 (0.37-3.85) 0.766
114 (67.9%)
21 (12.5%) 1 (0.6%)
30 
(17.9%)
2 
(1.2%)
0
0
Rectal specimens 
146/154 (94.8%)
Throat specimens 
51/92 (55.4%)
CSF specimens 
3/40 (7.5%)
Fig. 4. Origins and numbers (percentage) of enterovirus positive samples on RT-PCR 
in the Republic of Korea in 2009. CSF, cerebrospinal fluid.
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vations and effective measures for these symptoms would be 
necessary. 
 In this study, hyperglycemia and leukocytosis at admission 
were not statistically significant risk factors of complications. 
These findings were not present on admission of the expired 
patients in this study, only manifested after witnessing declin-
ing consciousness and the worsening patient’s condition. The 
results of this study led us to believe that clinicians would not be 
able to predict looming complications with mere general labo-
ratory findings. However, the finding of hyperglycemia or leu-
kocytosis in patients with HFMD or HP may already reflect the 
considerable progression of complications. 
 Chen et al. (22) reported, akin to the results of this study, that 
hyperglycemia or leukocytosis were signs after the progression 
of the disease itself, rather than risk factors of complications. 
However, there were reports in which hyperglycemia and leu-
kocytosis were investigated as the risk factors for fatal enterovi-
rus 71 infections (19, 25). 
 In this study, the mean CRP was significantly lower in the com-
plications group. It might reflect that inflammatory responses 
were low in the complications group. Owing to weak inflamma-
tory responses toward viruses in patients with HFMD or HP ac-
companied by complications, viral proliferation would not ef-
fectively be suppressed. As a result, a severe clinical progression 
might ensue. Additional study is necessary for this pathophysi-
ologic mechanism.
 The viral diagnostic sensitivity was the highest in the stool 
specimens in this study. However, according to Ooi et al. (26), 
the diagnostic sensitivity for enterovirus 71 was the highest in 
the throat swab specimens. It is advisable for clinicians to take 
two or more specimens in order to increase diagnostic sensitiv-
ity. This study showed that the enterovirus 71 subgenogroup 
epidemic in the ROK, 2009, was enterovirus 71 C4a. This was 
97% homologous to enterovirus 71 C4a, which had been preva-
lent in China, 2008 (8). Nevertheless, enterovirus 71 was not an 
epidemic in the ROK in 2008. Thus, the enterovirus 71 epidemic 
in China might have been introduced to the ROK in 2009. A re-
port claimed that a gradual increase in recent international travel 
often introduce epidemic viruses from one country to neighbor 
countries (27). Thus, it is necessary to monitor not only the state 
of the domestic enterovirus 71 epidemic but also of other coun-
tries.
 The HFMD or HP patients with neurologic complications 
could progress to death within a few days after development of 
fever. However, at primary hospital, diagnosis and treatment 
while conducting tests searching for causative viruses would 
not be possible in reality. Therefore, it is of utmost importance 
to find risk factors associated with development of complica-
tions based on clinical symptoms. In this study, rash patterns of 
HFMD rather than HP, fever longer than 4 days, peak body tem-
perature over 39°C, vomiting, headache and neurologic signs 
were associated with complications. Also, neurologic signs in-
cluded ataxia, gait disturbance, lower extremity weakness, sei-
zure, lethargy and coma. Ooi et al. (24) reported that fever longer 
than 3 days, peak temperature over 38.5°C and history of leth-
argy were identified as independent risk factors for a neurologi-
cal involvement. Chang et al. (19) reported that fever for longer 
than 3 days, peak body temperature over 39°C, headache, leth-
argy, vomiting, and seizure were associated with a central ner-
vous system involvement with an enterovirus 71 infection. Put-
ting these various reports together up to now, higher fever, lon-
ger fever duration, as well as meningeal irritation or other neu-
rologic signs, are common risk factors of central nervous system 
complications. In times of HFMD or HP epidemic, early detec-
tion and timely proper management of patients with such risk 
factors are essential.
 Until now, there is no vaccine or antiviral agent effective against 
enteroviruses-caused HFMD or HP. However, there was a re-
port, although additional verifications are required, that timely 
administration of intravenous immunoglobulin (IVIG) for se-
vere enterovirus 71 patients had reduced acute mortality (28-
30). Thus, attempts of close monitoring and timely IVIG infu-
sion would be necessary for patients with the above mentioned 
risk factors.
 Our study has some limitations due to its retrospective nature. 
Firstly, we did not investigate potentially important epidemio-
logic factors likewise number of children and adults in a family, 
history of HFMD or HP before admission, intrafamilial or out-
side contact with HFMD or HP, enrollment in a kindergarten or 
child care center. Secondly, each patient’s specimens were not 
collected at the same time from disease onset. Thirdly, we inves-
tigated only hospitalized patient, therefore our result may be 
not applicable to primary care setting.
 In conclusion, in cases of having rash patterns of HFMD rath-
er than HP, fever longer than 4 days, peak body temperature 
over 39°C, vomiting, headache, neurologic signs, serum glucose 
over 100 mg/dL and enterovirus 71 as a causative virus might 
be indicative of a grave prognosis in times of HFMD or HP epi-
demic. Therefore, early recognition and especially meticulous 
management in patients with these risk factors are requisite. 
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